The greater part of third quarter earnings results are in the rearview mirror. So far, the Q3 earnings season is off to a ...

Analysts also weigh in on Chesapeake Utilities, Halozyme Therapeutics, Sea Ltd., and Roper Technologies. Trump reverses on tariffs for some imports, Bitcoin falls on details of strategic reserve, ...

The first was a one-time stock option exchange program for non-Executive Committee employees, which received significant support from stockholders. The second proposal allowed for the adjournment of ...

The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to reports from The Walt Disney Company and Alibaba . So far, ...

Second-quarter earnings of $1.64 a share at the oil giant top analysts’ estimates. Chevron Stock Rises After Earnings. These Concerns Remain. The energy explorer just closed the acquisition of Hess, ...

The S&P 500 Healthcare sector (XLV) experienced a slight rise in average short interest during October, moving from 1.91% to ...

Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

Strong financial position with cash, cash equivalents and marketable securities of $93.7M Moderna litigation U.S. trial scheduled for March ...

In this week's STATus Report, STAT reporters Jason Mast and Damian Garde discuss the challenges facing Moderna — and what could be in store for its third act.

The story of the pharmaceutical company Moderna almost reads like a Hollywood screenplay. In its relatively short life, it ...

Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.

A Foundation for Accountability and Civic Trust complaint says Rep. Crockett has filed inconsistent financial disclosure ...